How Baseline Assessment of AMD Lesion Type Influences Clinical Decisions and Outcomes
Careful diagnosis and phenotyping of neovascular AMD patients is still required in the anti-VEGF era
Great Debates in RVO Therapy
An anti-VEGF and steroid gain FDA sanction, but many clinical questions remain
A Brave New World
The retina subspecialty is in the vanguard of changes to clinical practice and reimbursement